Admescope Ltd

Admescope launches services for biologics

Thu, Nov 01, 2018 11:00 CET

Free for publication on 1st of November 2018, at 12.00 p.m. (CET) OULU, FINLAND, November 1st, 2018. Admescope Ltd, a provider of ADME-Tox contract research services, announced today the launch of services for a new category; Biologics. The number of drug development projects with biological drugs has been continuously increasing over the past decade and therefore, the expansion to serve this growing market was a logical continuation for Admescope’s service development, after having previously built a strong and comprehensive service portfolio for the research of small molecules

Admescope has acquired MetaSafe AB

Wed, Jun 06, 2018 12:00 CET

OULU, FINLAND, June 6, 2018. Admescope Ltd, a pre-clinical ADME-Tox service provider today announced the acquisition of MetaSafe AB, a company specialised in the field of metabolic biotransformation research. MetaSafe, based in Södertälje, Sweden, is a contract research organisation working with small, midsize and large pharmaceutical companies in the area of drug biotransformation/metabolism. MetaSafe is especially focusing on clinical phase drug metabolism studies from safety perspective, but also provides services for preclinical stage of drug development. Admescope, having the

Share

Admescope launches services for biologics

Admescope has acquired MetaSafe AB